Background
Artificial Intelligence (“AI”) has been utilized by innovative companies across the array of industry spaces, but its impact on
Continue Reading Key IP Licensing Considerations for AI Drug Discovery Platforms
Target Acquired, Protein Deleted: The Next Frontier in Precision Medicine and IP Strategy
Introduction: Harnessing Cellular Machinery for Precision Medicine
Targeted protein degradation (TPD) is transforming drug discovery by leveraging the cell’s natural
Continue Reading Target Acquired, Protein Deleted: The Next Frontier in Precision Medicine and IP Strategy
mRNA/LNP Patent Litigation Update (Q1 2025)
As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and collaborators
Continue Reading mRNA/LNP Patent Litigation Update (Q1 2025)
Key Patent Considerations for Antibody Drug Conjugates (ADCs)
In 1910, German scientist Paul Ehrlich introduced a groundbreaking concept to the world: chemical compounds could be engineered to interact
Continue Reading Key Patent Considerations for Antibody Drug Conjugates (ADCs)
CRISPR and Agriculture
Co-authored by Sheena Wang and Ellie Purnell of HGF limited, “CRISPR and Agriculture” was originally published by Food and Drink
Continue Reading CRISPR and Agriculture
The Future of Food: Regulatory and Patent Landscape of Genome Editing in Food Technology
Our current food system is facing a myriad of critical challenges. The United Nations predicts that the world population will
Continue Reading The Future of Food: Regulatory and Patent Landscape of Genome Editing in Food Technology
This Summer in Artificial Intelligence: Newly Released USPTO Guidance and Exemplary Worldwide Inventorship Updates
The Unted States Patent and Trademark Office (USPTO) recently published new guidance on subject-matter eligibility as related to Artificial Intelligence
Continue Reading This Summer in Artificial Intelligence: Newly Released USPTO Guidance and Exemplary Worldwide Inventorship Updates
Client Spotlight: BASE Air Management
BASE Air is a company at the leading edge of safety in the heavy vehicle industry. Founded in 2005 by
Continue Reading Client Spotlight: BASE Air Management
Gene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell Disease
In a long-awaited milestone in the gene therapy space, the Food and Drug Administration (FDA) approved two gene therapies to
Continue Reading Gene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell Disease
Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024
Gene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024